An Open Label Phase II Study Combining Nivolumab and Celecoxib in Patients With Advanced " Cold " Solid Tumors
Clinical trial NCT03864575 · UNKNOWN
Trial details
- NCT number
- NCT03864575
- Sponsor
- Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-15
- Primary completion
- 2021-06-15
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.